Market Considerations in Europe Outlook - Featured Research on Human Genome Sciences and Ford Motor Company
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 11/14/11 -- Today, introduced featured coverage of Human Genome Sciences (NASDAQ: HGSI) and Ford Motor Company (NYSE: F). Full research reports are available to readers at: .
With the European Financial Stability Facility set to increase to $1.4 trillion, it marks a significant move forward to strengthen the safety net in place for Europe's most troubled countries. Private bondholders of Greek debt are settling at a 50% haircut as another $180 billion in fresh aid is set to arrive, enabling banks to recapitalize at a healthy 9% reserve. Overall, these measures will bring Greece's debt burden down to 120% of GDP by 2020. An important consideration is political commitment to this road map. Currently the global community appears to be on point with ECB's initiative, an outlook that should be sufficient to support markets around current levels.
Bollinger Report screened and selected Human Genome Sciences for its current position within the healthcare industry. Human Genome Sciences, Inc. (HGS) is a biopharmaceutical company. The Company's products are BENLYSTA (belimumab) for systemic lupus erythematosus (SLE) and raxibacumab for inhalation anthrax. GlaxoSmithKline (GSK) is a HGS partner in the co-development and commercialization of BENLYSTA. A copy of this report featuring Human Genome Sciences (NASDAQ: HGSI) is available at: .
Bollinger Report is featuring Ford Motor Company for its changing role within the consumer goods industry. Ford Motor Company (Ford) is a producer of cars and trucks. Ford and its subsidiaries are also engaged in other businesses, including financing vehicles. It operates under two segments: Automotive and Financial Services. Automotive segment includes the operations of Ford North America, Ford South America, Ford Europe and Ford Asia Pacific Africa. To download researches and analysis on Ford Motor Company (NYSE: F) we welcome investors to visit: .
About Bollinger Report
Bollinger Report has come to be known among its peers as a trusted source of information for both investors and technical traders. Our online content is continually updated, bringing fresh new researches and analyses to the investment community.
Contact:
Martin Schwartz
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 14.11.2011 - 14:00 Uhr
Sprache: Deutsch
News-ID 87417
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 147 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Market Considerations in Europe Outlook - Featured Research on Human Genome Sciences and Ford Motor Company"
steht unter der journalistisch-redaktionellen Verantwortung von
Bollinger Report (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
